OR2AE1

Across TCGA pan-cancer cohorts, OR2AE1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OR2AE1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR2AE1 RNA is repressed in tumor relative to normal tissue. In most cancer types OR2AE1 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

HNSC, LIHC, and KIRC are the cancer types where OR2AE1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR2AE1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	−0.039	.018	4	view →
LIHC	All	II,III,IV	+0.022	.027	2	view →
KIRC	Male	All	+0.042	.034	1	view →
COAD	All	All	+0.025	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

OR2AE1–HNSC

Open the HNSC breakdown →